Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial

MLA

Jia Guan, et al. “Machine-Learning Model Derived Gene Signature Predictive of Paclitaxel Survival Benefit in Gastric Cancer: Results from the Randomised Phase III SAMIT Trial.” Gut, vol. 71, no. 4, Apr. 2022, pp. 676–85. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....59fa4c8e108a7d51dd70caa57096173a&authtype=sso&custid=ns315887.

APA

Jia Guan, Takaki Yoshikawa, Shiro Tanaka, Heike I. Grabsch, Yohei Miyagi, Yasushi Rino, Jeeyun Lee, Junichi Sakamoto, Nesaretnam Barr Kumarakulasinghe, Yiong Huak Chan, Takashi Oshima, Michal Marek Hoppe, Anand D. Jeyasekharan, Mark De Simone, Munetaka Masuda, Akira Tsuburaya, Kazuhiro Yoshida, Cedric Chuan Young Ng, Raghav Sundar, … Patrick Tan. (2022). Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial. Gut, 71(4), 676–685.

Chicago

Jia Guan, Takaki Yoshikawa, Shiro Tanaka, Heike I. Grabsch, Yohei Miyagi, Yasushi Rino, Jeeyun Lee, et al. 2022. “Machine-Learning Model Derived Gene Signature Predictive of Paclitaxel Survival Benefit in Gastric Cancer: Results from the Randomised Phase III SAMIT Trial.” Gut 71 (4): 676–85. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....59fa4c8e108a7d51dd70caa57096173a&authtype=sso&custid=ns315887.